CDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901 study Dr. Divya Colin4 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organisation (CDSCO), has approved AstraZeneca...
Johnson & Johnson gets CDSCO Panel for additional indication of Amivantamab Liquid Concentrate for Infusion Dr. Divya Colin12 April 2025 5:45 AM ISTNew Delhi: In a significant development, the drug major Johnson and Johnson has got the go-ahead from the Subject Expert Committee (SEC) functional...
Novartis Healthcare Gets CDSCO Panel Nod To study Anti-cancer Drug Asciminib Dr. Divya Colin6 April 2025 3:30 AM ISTNew Delhi: Pharmaceutical major Novartis Healthcare has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Pfizer Gets CDSCO Panel Nod To Study Anticancer Drug Disitamab vedotin Dr. Divya Colin22 March 2025 6:00 PM ISTNew Delhi: Citing that more geographically distributed government sites shall be included in the study, the Subject Expert Committee (SEC) functional...
Conduct BE study or present safety data: CDSCO Panel tells IQVIA on anti-cancer Drug Daratumumab study Dr. Divya Colin15 March 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined IQVIA to conduct the...
BDR Pharmaceutical Gets CDSCO Panel Nod To Manufacture Market anticancer drug Tucatinib Tablets Dr. Divya Colin9 March 2025 6:00 PM ISTNew Delhi: Agreeing for Phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel approves Dr Reddys proposal to increase patients from 241 to 265 in India for anticancer drug Nivolumab study Dr. Divya Colin12 Jan 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
CDSCO Panel Approves Eli Lilly's Protocol Amendment proposal to study Anti-cancer Drug LY3537982 Dr. Divya Colin10 Jan 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Pfizer Gets CDSCO Panel Nod To Study Anti-cancer Drug PF-07220060 Dr. Divya Colin9 Jan 2025 6:00 PM ISTNew Delhi: The drug major Pfizer has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca Gets CDSCO Panel Nod To study Anti-Cancer Drug Rilvegostomig Dr. Divya Colin27 Dec 2024 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Standard Control...
CDSCO Panel Approves GSK Protocol Amendment proposal for Belrestotug and Dostarlimab study Dr. Divya Colin27 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
BDR Pharmaceuticals Gets CDSCO Panel Nod for bioequvalence study of Abiraterone Acetate Oral Suspension Dr. Divya Colin25 Dec 2024 6:15 PM ISTNew Delhi: BDR Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
